Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.37 EUR | +0.24% | -2.34% | -3.07% |
05-31 | Qiagen, Myriad Genetics Team Up to Develop Homologous Recombination Deficiency Test | MT |
05-31 | Qiagen, Myriad Genetics Partner to Create Easily Distributable Cancer Tumor Test | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
54.63B | - | |||||
39.92B | ||||||
26.86B | ||||||
26.22B | ||||||
18.78B | - |